Indian drugmaker Granules has issued a voluntary recall of more than 33,000 bottles of the generic high blood pressure treatment metoprolol succinate, citing the drug's failure to meet dissolution ...

The Hyderabad-based drug maker is recalling 33,024 bottles of Metoprolol Succinate extended-release tablets in 100 count and ...

Granules India is recalling more than 33,000 bottles of a generic blood pressure lowering medication from US shelves due to ...

Granules recalls 33,000+ bottles of Metoprolol Succinate due to failed dissolution specifications, per FDA enforcement report ...

Granules India recalls 33,000 bottles of Metoprolol Succinate due to manufacturing issues. The US FDA initiated a Class II recall.

The company had intentionally scaled down production to focus on remediation and expects that volume to return as operations normalise.